PLOS
open access
CC BY
The effect of STAT1 expression and the Y701 phosphorylation on primary Undifferentiated Pleomorphic Sarcoma cells
Undifferentiated Pleomorphic Sarcoma (UPS) is a genetically complex type of soft tissue sarcoma (STS) and there are few therapeutic options for advanced disease. Immune checkpoint blockade therapy may be of benefit to a subset of UPS patients, particularly those with elevated tumoral Programmed Cel
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma#867657
- YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases#1383734
- Combination Immunotherapy Targeting Sarcomas#140994
- Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma#366595
- Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma#979967
Record · ID 1460542
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive